# INVESTOR B

Summary updated: 2026-03-19T19:33:16.200834Z
Canonical: https://finbar.com/research/companies/investor-b

## Overview

Investor AB is a Sweden-based long-term investment company and active owner founded by the Wallenberg family in 1916. Its role is to allocate capital, exercise ownership and governance, and support the development of businesses through substantial ownership stakes and board participation rather than producing products directly. The company is organized around three business areas: Listed Companies, Patricia Industries, and Investments in EQT. Its stated purpose is to create value for people and society by building strong and sustainable businesses, with a focus on maximizing long-term value through sustainable business development and innovation. [1](https://app.finbar.com/go?id=P-c0b96391791b4266ab01c72c2134e81b)[2](https://app.finbar.com/go?id=P-462eb33385ca4d7682acc364e78544e3)[3](https://app.finbar.com/go?id=P-9400331f2c5e47508f157813bb7cd6db)[4](https://app.finbar.com/go?id=P-35e3885aa61d48328832b29ff353a2dc)

Through its holdings, Investor has exposure to sectors including industrial technology, telecommunications, healthcare and life sciences, financial services, consumer appliances, defense, and marine and industrial equipment. Its major holdings include companies such as Atlas Copco, ABB, Ericsson, AstraZeneca, SEB and Saab, while Patricia Industries includes wholly owned and controlled businesses such as Mölnlycke, Permobil, Piab Group, Sarnova and Laborie. The company’s reach is global through these portfolio companies, with sales generated across major regions. As a scale indicator, Investor reported adjusted net asset value of SEK 970 billion and total adjusted assets of SEK 982 billion at the end of 2024, while its portfolio companies employed about 520,000 people. [5](https://app.finbar.com/go?id=P-106ec7591a604a1e866c9ee43d05b2b3)[6](https://app.finbar.com/go?id=P-11aab41209be410295df4eb75ade4e28)[7](https://app.finbar.com/go?id=P-7defd59046a9464ea01ee59080fd6a96)[8](https://app.finbar.com/go?id=P-57383a1973674423a3b184e7f59fc760)[9](https://app.finbar.com/go?id=P-f267e89cad2f41369fba1ab418b3b26e)[10](https://app.finbar.com/go?id=P-f79822785d38473ca29199980bd06a28)[11](https://app.finbar.com/go?id=P-6f876ad6a1a6440ba1ec3fc0e76c9b12)[12](https://app.finbar.com/go?id=P-3589504bf9e34cd3b3e7ad60255facc9)[13](https://app.finbar.com/go?id=P-3c0e8f37334f43a2b751c1f8c5a5a272)[14](https://app.finbar.com/go?id=P-26dbd7646eca49d7a3c6681cb7e5ddc7)[15](https://app.finbar.com/go?id=P-3cb2f022d2a048eb85bb44eaf62e5e47)[16](https://app.finbar.com/go?id=P-d73d40f500aa4b6b9b8010ac52ab9156)
[1](https://app.finbar.com/go?id=P-c0b96391791b4266ab01c72c2134e81b)[2](https://app.finbar.com/go?id=P-462eb33385ca4d7682acc364e78544e3)[3](https://app.finbar.com/go?id=P-9400331f2c5e47508f157813bb7cd6db)[4](https://app.finbar.com/go?id=P-35e3885aa61d48328832b29ff353a2dc)[5](https://app.finbar.com/go?id=P-106ec7591a604a1e866c9ee43d05b2b3)[6](https://app.finbar.com/go?id=P-11aab41209be410295df4eb75ade4e28)[7](https://app.finbar.com/go?id=P-7defd59046a9464ea01ee59080fd6a96)[8](https://app.finbar.com/go?id=P-57383a1973674423a3b184e7f59fc760)[9](https://app.finbar.com/go?id=P-f267e89cad2f41369fba1ab418b3b26e)[10](https://app.finbar.com/go?id=P-f79822785d38473ca29199980bd06a28)[11](https://app.finbar.com/go?id=P-6f876ad6a1a6440ba1ec3fc0e76c9b12)[12](https://app.finbar.com/go?id=P-3589504bf9e34cd3b3e7ad60255facc9)[13](https://app.finbar.com/go?id=P-3c0e8f37334f43a2b751c1f8c5a5a272)[14](https://app.finbar.com/go?id=P-26dbd7646eca49d7a3c6681cb7e5ddc7)[15](https://app.finbar.com/go?id=P-3cb2f022d2a048eb85bb44eaf62e5e47)[16](https://app.finbar.com/go?id=P-d73d40f500aa4b6b9b8010ac52ab9156)

## Products & services

At the parent-company level, Investor AB is an investment holding company rather than a direct product manufacturer, so its concrete product disclosures are mainly through Patricia Industries subsidiaries. The clearest product mix disclosure is for Mölnlycke, whose offering is organized into Wound Care, Operating Room Solutions, Gloves and Antiseptics; these represented 59%, 25%, 12% and 3% of Mölnlycke sales, respectively. Within Wound Care, the Post-op and Prevention segments were specifically highlighted as strong contributors. Mölnlycke describes Wound Care as solutions for healing and preventing wounds, Operating Room Solutions as products and workflow support across surgical procedures, Biogel gloves as surgical gloves designed for protection and hand performance, and Antiseptics as antimicrobial products intended to reduce infection risk.[17](https://app.finbar.com/go?id=P-67eb8d0b14384e1fbe011708737c0138)[18](https://app.finbar.com/go?id=P-2755c8de96a9425f906909fb4cd0e931)[19](https://www.molnlycke.com/corporate/solutions/wound-care-solutions/)[20](https://www.molnlycke.com/corporate/about/our-expertise/or-solutions/)[21](https://www.molnlycke.com/en-us/products/gloves/surgical-gloves/)[22](https://www.molnlycke.com/en-us/products/antiseptics/)

Other named product and service exposures are disclosed at the subsidiary level. Laborie is described as a medical technology company focused on Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal, with diagnostic and therapeutic products and brands including Koala, Kiwi and SweetUms; a specifically named product is Optilume, which Laborie describes as a drug-coated balloon for male anterior urethral strictures that combines mechanical dilation with localized paclitaxel delivery, and it also markets an Optilume system for BPH.[23](https://app.finbar.com/go?id=P-62fe0c223ca3433aa0edef0af8e06d46)[24](https://www.laborie.com/about-us/)[25](https://www.laborie.com/products/)[26](https://www.laborie.com/obstetrics/)[27](https://www.laborie.com/product/optilume-drug-coated-balloon-for-urethral-stricture-treatment/)[28](https://www.laborie.com/product/optilume-for-bph/) Other Patricia Industries companies are described more broadly by product type: piab group provides gripping and moving solutions; Permobil provides advanced mobility solutions; Sarnova supplies specialty healthcare and safety products, services and software; BraunAbility provides mobility transportation solutions including wheelchair-accessible vehicles; Advanced Instruments provides scientific and analytical instruments for biotechnology, clinical, and food and beverage uses; and Atlas Antibodies provides reagents for biomedical research.[29](https://app.finbar.com/go?id=P-96e786560024483ba069d6e176fef125)[30](https://app.finbar.com/go?id=P-f2322b028a5345e7bdc5dff7158bb6a4)[31](https://app.finbar.com/go?id=P-f643258dd2f24b728bc0ae32160bca7b)[32](https://app.finbar.com/go?id=P-b513f64e334d42ca8a9ea15c9a72c9c7)[33](https://app.finbar.com/go?id=P-cf6e27223b5e494aa12c8fb30fa60dbc)[34](https://app.finbar.com/go?id=P-ea4c53b3ee9343d9adab6e615663a7ee)
[17](https://app.finbar.com/go?id=P-67eb8d0b14384e1fbe011708737c0138)[18](https://app.finbar.com/go?id=P-2755c8de96a9425f906909fb4cd0e931)[23](https://app.finbar.com/go?id=P-62fe0c223ca3433aa0edef0af8e06d46)[29](https://app.finbar.com/go?id=P-96e786560024483ba069d6e176fef125)[30](https://app.finbar.com/go?id=P-f2322b028a5345e7bdc5dff7158bb6a4)[31](https://app.finbar.com/go?id=P-f643258dd2f24b728bc0ae32160bca7b)[32](https://app.finbar.com/go?id=P-b513f64e334d42ca8a9ea15c9a72c9c7)[33](https://app.finbar.com/go?id=P-cf6e27223b5e494aa12c8fb30fa60dbc)[34](https://app.finbar.com/go?id=P-ea4c53b3ee9343d9adab6e615663a7ee)[19](https://www.molnlycke.com/corporate/solutions/wound-care-solutions/)[20](https://www.molnlycke.com/corporate/about/our-expertise/or-solutions/)[21](https://www.molnlycke.com/en-us/products/gloves/surgical-gloves/)[22](https://www.molnlycke.com/en-us/products/antiseptics/)[24](https://www.laborie.com/about-us/)[25](https://www.laborie.com/products/)[26](https://www.laborie.com/obstetrics/)[27](https://www.laborie.com/product/optilume-drug-coated-balloon-for-urethral-stricture-treatment/)[28](https://www.laborie.com/product/optilume-for-bph/)

## Geographic presence

Investor AB is headquartered at Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden, and has offices in Sweden, the United States and the Netherlands.[35](https://app.finbar.com/go?id=P-9740b338453c48fc8cdff187bb7df95b)[36](https://app.finbar.com/go?id=P-32295689a27840129af55b1735d705e8) Its directly employed workforce totals 105 professionals, with 89 based in the Stockholm headquarters, 15 in New York City and 1 in Amsterdam.[36](https://app.finbar.com/go?id=P-32295689a27840129af55b1735d705e8) The company also notes that Investor and many of its companies have headquarters in Sweden.[37](https://app.finbar.com/go?id=P-ed60ca8fbbe540e09dc587516437109f)

The most detailed regional sales disclosure available is for Investor AB’s Life science field of operations, where revenue is allocated based on where customers use the products and services.[38](https://app.finbar.com/go?id=P-bb1bdf5f836140438da7018705d56e61) In 2024, the U.S. was the largest market at 37,838, or 59.9% of revenue, followed by Europe excluding Scandinavia at 15,520, or 24.6%.[39](https://app.finbar.com/go?id=P-3bf4428e58e44415a046b186a37483fc) Sweden accounted for 1,800, or 2.9%, Scandinavia excluding Sweden for 1,690, or 2.7%, North America excluding the U.S. for 1,445, or 2.3%, South America for 572, or 0.9%, Australia for 1,262, or 2.0%, Asia excluding China for 1,601, or 2.5%, and China for 1,026, or 1.6%.[39](https://app.finbar.com/go?id=P-3bf4428e58e44415a046b186a37483fc) On that basis, Europe including Scandinavia represented about 30.1% of Life science revenue, while the Americas represented about 63.1%.[39](https://app.finbar.com/go?id=P-3bf4428e58e44415a046b186a37483fc)
[35](https://app.finbar.com/go?id=P-9740b338453c48fc8cdff187bb7df95b)[36](https://app.finbar.com/go?id=P-32295689a27840129af55b1735d705e8)[37](https://app.finbar.com/go?id=P-ed60ca8fbbe540e09dc587516437109f)[38](https://app.finbar.com/go?id=P-bb1bdf5f836140438da7018705d56e61)[39](https://app.finbar.com/go?id=P-3bf4428e58e44415a046b186a37483fc)

## Business segments

Investor reports three operating segments based on how management reviews the business: Listed Companies, Patricia Industries, and Investments in EQT; non-allocated investing activities are shown separately in Investor Groupwide.[40](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464) Listed Companies comprises Investor’s listed holdings and is described as an engaged-ownership portfolio built around significant minority stakes.[40](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464)[41](https://app.finbar.com/go?id=P-613429a3739346708ebc5a6f3d84abdf) Patricia Industries includes wholly owned subsidiaries, Tre Skandinavien, the former IGC portfolio, and other financial investments outside Investor’s trading portfolio; Investor also characterizes it more broadly as wholly owned subsidiaries, partner-owned companies, and financial investments.[40](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464)[42](https://app.finbar.com/go?id=P-7ec6a5dda2274c518dc2ac5c90ccaebd) Investments in EQT consists of Investor’s holdings in EQT AB and EQT funds.[40](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464)

Using Investor’s 2024 asset mix as an approximate segment weighting, Listed Companies represented about 68% of total assets (SEK 670bn), Patricia Industries about 23% (SEK 223bn), and Investments in EQT about 9% (SEK 89bn).[43](https://app.finbar.com/go?id=P-50827e7aa4444ee6a0619ccb77f251d9)[44](https://app.finbar.com/go?id=P-14fda898bdbc4164aee878b646367340)[45](https://app.finbar.com/go?id=P-a4bec42cc3a942d5be53552c0d69afa2) Investor Groupwide is not a standalone operating business area; it captures non-allocated items such as management costs, net financial items, tax components, and related assets and liabilities.[40](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464)
[40](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464)[41](https://app.finbar.com/go?id=P-613429a3739346708ebc5a6f3d84abdf)[42](https://app.finbar.com/go?id=P-7ec6a5dda2274c518dc2ac5c90ccaebd)[43](https://app.finbar.com/go?id=P-50827e7aa4444ee6a0619ccb77f251d9)[44](https://app.finbar.com/go?id=P-14fda898bdbc4164aee878b646367340)[45](https://app.finbar.com/go?id=P-a4bec42cc3a942d5be53552c0d69afa2)

## Company history

Investor AB was founded in Stockholm in 1916 by the Wallenberg family as a holding company after shareholdings were transferred out of Stockholms Enskilda Bank, and its shares were listed on the Stockholm Stock Exchange in 1917.[46](https://www.investorab.com/about-investor/investors-history/1916-1929) During the early decades it expanded its industrial base; in 1932 the Wallenberg sphere increased its holding in SKF, added a minority stake in LM Ericsson and acquired a large interest in Swedish Match.[47](https://www.investorab.com/about-investor/investors-history/1929-1963)

Investor began to build a more formal executive structure in the postwar period, appointing its first CEO, Frans G. Liljenroth, in 1949.[47](https://www.investorab.com/about-investor/investors-history/1929-1963) Major portfolio milestones followed in later decades: Saab and Scania-Vabis merged in 1969, and Asea and Brown Boveri merged in 1986 to form ABB.[48](https://www.investorab.com/about-investor/investors-history/1963-1978)[49](https://www.investorab.com/about-investor/investors-history/1984-1994) In 1995, Saab-Scania was split into Scania AB and Saab AB, marking another major reshaping of the portfolio.[50](https://www.investorab.com/about-investor/investors-history/1995-2004)

A new phase began in 2005, when Jacob Wallenberg became chairman and Börje Ekholm was appointed President and CEO.[51](https://www.investorab.com/about-investor/investors-history/2005-2014) Investor continued to reorganize and expand its holdings, including taking Gambro private with EQT in 2006 and acquiring Mölnlycke Health Care with partners in 2007.[51](https://www.investorab.com/about-investor/investors-history/2005-2014) In 2015 Johan Forssell became CEO and Investor introduced a portfolio structure built around Listed Core Investments, EQT and Patricia Industries; the company marked its 100-year anniversary in 2016.[52](https://www.investorab.com/about-investor/investors-history/2015) Christian Cederholm became President and CEO in 2024.[53](https://www.investorab.com/about-investor/board-management/executive-leadership-team/executive-leadership-team/christian-cederholm/)
[46](https://www.investorab.com/about-investor/investors-history/1916-1929)[47](https://www.investorab.com/about-investor/investors-history/1929-1963)[48](https://www.investorab.com/about-investor/investors-history/1963-1978)[49](https://www.investorab.com/about-investor/investors-history/1984-1994)[50](https://www.investorab.com/about-investor/investors-history/1995-2004)[51](https://www.investorab.com/about-investor/investors-history/2005-2014)[52](https://www.investorab.com/about-investor/investors-history/2015)[53](https://www.investorab.com/about-investor/board-management/executive-leadership-team/executive-leadership-team/christian-cederholm/)

## Sources

1. [INVESTOR B — Full financial report (2024 Y), p3](https://app.finbar.com/go?id=P-c0b96391791b4266ab01c72c2134e81b)
2. [INVESTOR B — Full financial report (2024 Y), p5](https://app.finbar.com/go?id=P-462eb33385ca4d7682acc364e78544e3)
3. [INVESTOR B — Full financial report (2024 Y), p5](https://app.finbar.com/go?id=P-9400331f2c5e47508f157813bb7cd6db)
4. [INVESTOR B — Full financial report (2024 Y), p5](https://app.finbar.com/go?id=P-35e3885aa61d48328832b29ff353a2dc)
5. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-106ec7591a604a1e866c9ee43d05b2b3)
6. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-11aab41209be410295df4eb75ade4e28)
7. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-7defd59046a9464ea01ee59080fd6a96)
8. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-57383a1973674423a3b184e7f59fc760)
9. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-f267e89cad2f41369fba1ab418b3b26e)
10. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-f79822785d38473ca29199980bd06a28)
11. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-6f876ad6a1a6440ba1ec3fc0e76c9b12)
12. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-3589504bf9e34cd3b3e7ad60255facc9)
13. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-3c0e8f37334f43a2b751c1f8c5a5a272)
14. [INVESTOR B — Presentation (2024 Y), p10](https://app.finbar.com/go?id=P-26dbd7646eca49d7a3c6681cb7e5ddc7)
15. [INVESTOR B — Presentation (2024 Y), p4](https://app.finbar.com/go?id=P-3cb2f022d2a048eb85bb44eaf62e5e47)
16. [INVESTOR B — Full financial report (2024 Y), p5](https://app.finbar.com/go?id=P-d73d40f500aa4b6b9b8010ac52ab9156)
17. [INVESTOR B — Presentation (2024 Y), p10](https://app.finbar.com/go?id=P-67eb8d0b14384e1fbe011708737c0138)
18. [INVESTOR B — Presentation (2024 Y), p10](https://app.finbar.com/go?id=P-2755c8de96a9425f906909fb4cd0e931)
19. [www.molnlycke.com](https://www.molnlycke.com/corporate/solutions/wound-care-solutions/)
20. [www.molnlycke.com](https://www.molnlycke.com/corporate/about/our-expertise/or-solutions/)
21. [www.molnlycke.com](https://www.molnlycke.com/en-us/products/gloves/surgical-gloves/)
22. [www.molnlycke.com](https://www.molnlycke.com/en-us/products/antiseptics/)
23. [INVESTOR B — Presentation (2024 Y), p8](https://app.finbar.com/go?id=P-62fe0c223ca3433aa0edef0af8e06d46)
24. [www.laborie.com](https://www.laborie.com/about-us/)
25. [www.laborie.com](https://www.laborie.com/products/)
26. [www.laborie.com](https://www.laborie.com/obstetrics/)
27. [www.laborie.com](https://www.laborie.com/product/optilume-drug-coated-balloon-for-urethral-stricture-treatment/)
28. [www.laborie.com](https://www.laborie.com/product/optilume-for-bph/)
29. [INVESTOR B — Partial financial report (2025 Y), p12](https://app.finbar.com/go?id=P-96e786560024483ba069d6e176fef125)
30. [INVESTOR B — Full financial report (2024 Y), p41](https://app.finbar.com/go?id=P-f2322b028a5345e7bdc5dff7158bb6a4)
31. [INVESTOR B — Partial financial report (2025 Y), p11](https://app.finbar.com/go?id=P-f643258dd2f24b728bc0ae32160bca7b)
32. [INVESTOR B — Partial financial report (2023 Y), p12](https://app.finbar.com/go?id=P-b513f64e334d42ca8a9ea15c9a72c9c7)
33. [INVESTOR B — Partial financial report (2023 Y), p12](https://app.finbar.com/go?id=P-cf6e27223b5e494aa12c8fb30fa60dbc)
34. [INVESTOR B — Partial financial report (2024 H 1), p13](https://app.finbar.com/go?id=P-ea4c53b3ee9343d9adab6e615663a7ee)
35. [INVESTOR B — Full financial report (2024 Y), p171](https://app.finbar.com/go?id=P-9740b338453c48fc8cdff187bb7df95b)
36. [INVESTOR B — Full financial report (2024 Y), p86](https://app.finbar.com/go?id=P-32295689a27840129af55b1735d705e8)
37. [INVESTOR B — Full financial report (2024 Y), p8](https://app.finbar.com/go?id=P-ed60ca8fbbe540e09dc587516437109f)
38. [INVESTOR B — Full financial report (2024 Y), p110](https://app.finbar.com/go?id=P-bb1bdf5f836140438da7018705d56e61)
39. [INVESTOR B — Full financial report (2024 Y), p111](https://app.finbar.com/go?id=P-3bf4428e58e44415a046b186a37483fc)
40. [INVESTOR B — Full financial report (2024 Y), p108](https://app.finbar.com/go?id=P-e3b253d0fc9e484abc3dc58d9ae21464)
41. [INVESTOR B — Full financial report (2024 Y), p28](https://app.finbar.com/go?id=P-613429a3739346708ebc5a6f3d84abdf)
42. [INVESTOR B — Full financial report (2024 Y), p7](https://app.finbar.com/go?id=P-7ec6a5dda2274c518dc2ac5c90ccaebd)
43. [INVESTOR B — Presentation (2024 Y), p6](https://app.finbar.com/go?id=P-50827e7aa4444ee6a0619ccb77f251d9)
44. [INVESTOR B — Presentation (2024 Y), p4](https://app.finbar.com/go?id=P-14fda898bdbc4164aee878b646367340)
45. [INVESTOR B — Presentation (2024 Y), p4](https://app.finbar.com/go?id=P-a4bec42cc3a942d5be53552c0d69afa2)
46. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/1916-1929)
47. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/1929-1963)
48. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/1963-1978)
49. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/1984-1994)
50. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/1995-2004)
51. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/2005-2014)
52. [www.investorab.com](https://www.investorab.com/about-investor/investors-history/2015)
53. [www.investorab.com](https://www.investorab.com/about-investor/board-management/executive-leadership-team/executive-leadership-team/christian-cederholm/)

AI-generated summary; may contain errors. Not investment advice. Sign up to Finbar to view original document sources and access worldwide fundamental financial data and intelligence.